ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Feature Stories FDA-Cleared Home Hemodialysis Technology for Treatment of Chronic Kidney DiseaseBy Radhika ShahDecember 2, 2022Chronic kidney disease (CKD) affects more than 1 in 7 U.S. adults and approximately 2 in 1,000 Americans live with… Read More
